The HRT furore: Getting the message right

Medical Journal of Australia

Volumn 177, Issue 7, 2002, Pages 345-346

  Patel, Anushka ^a   Norton, Robyn ^a   MacMahon, Stephen ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

AUSTRALIA; BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLORECTAL CANCER; CONFIDENCE INTERVAL; DEATH; EDITORIAL; ENDOMETRIUM CANCER; GENERAL PRACTITIONER; HEALTH HAZARD; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSAL SYNDROME; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STROKE; THROMBOEMBOLISM; VEIN THROMBOSIS; VERTEBRA FRACTURE;

EID: 0037038166     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04834.x     Document Type: Editorial

References (10)

1. NIH News Release. NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefit.
2. Cancer Council of New South Wales. Call to restrict combined hormone replacement therapy in wake of breast cancer link.
3. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
4. JAMA Science News Update. Health risks outweigh benefits for combined estrogen plus progestin - Clinical trial stopped early in major study.
5. Gittins R. Medicos are using selective surgery on their statistics. The Sydney Morning Herald 7 August 2002: 13.
6. Nexoe J, Gyrd-Hansen D, Kragstrup J, et al. Danish GPs' perception of disease risk and benefit of prevention. Fam Pract 2002; 19: 3-6.
7. Hux JE, Naylor CD. Communicating the benefits of chronic preventive therapy: Does the format of efficacy data determine patients' acceptance of treatment? Med Decis Making 1995; 15: 152-157.
8. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994; 309: 761-764.
9. Malenka DJ, Baron JA, Johansen S, et al. The framing effect of relative and absolute risk. J Gen Intern Med 1993; 8: 543-548.
10. Noble T. Women abandon suspect hormone therapy. The Age 19 August 2002: 1.